Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences

News > Health News

Audio By Carbonatix

6:00 AM on Thursday, February 26

The Associated Press

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 26, 2026--

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that management will participate in the following upcoming investor conferences, which are being conducted in-person:

TD Cowen 46th Annual Health Care Conference: Fireside Chat on Tuesday, March 3, 2026, at 11:10 a.m. ET in Boston, Massachusetts
Leerink Global Healthcare Conference: Fireside chat on Tuesday, March 10, 2026, at 8:00 a.m. ET in Miami, Florida

A live webcast of both presentations can be accessed under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/events-presentations, and will be available for replay for 90 days following the events.

About Amylyx Pharmaceuticals

At Amylyx, our mission is to usher in a new era of treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are currently focused on four investigational therapies across several endocrine conditions and neurodegenerative diseases in which we believe they can make the greatest impact. For more information, visit amylyx.com and follow us on LinkedIn and X. For investors, please visit investors.amylyx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260226194969/en/

CONTACT: Media

Amylyx Media Team

+1 (857) 320-6191

[email protected]

Investors

Lindsey Allen

Amylyx Pharmaceuticals, Inc.

+1 (857) 320-6244

[email protected]

KEYWORD: FLORIDA MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS